Great West Life Assurance CO Tg Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 14,474 shares of TGTX stock, worth $319,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,474
Previous 12,471
16.06%
Holding current value
$319,585
Previous $190,000
35.79%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$302 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$251 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$148 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$80.5 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$71.6 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.21B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...